| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
118,610,000 |
| Market
Cap: |
23.41(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1974 - $0.2732 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Oncocyte is a molecular diagnostics company focused on developing and commercializing proprietary laboratory-developed tests to serve unmet medical needs across the cancer care continuum. Co.'s DetermaRx™ is a predictive molecular test for early-stage adenocarcinoma of the lung. This test provides information that a physician can use to help identify early-stage, surgically resected patients with Stage I and IIA non-squamous non-small cell lung cancer who are at high-risk of recurrence and may benefit from chemotherapy. Co.'s portfolio includes a gene expression-based test called DetermaIO™, which is being developed to identify patients most likely to respond to immunotherapy drugs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,457,288 |
2,457,288 |
2,487,288 |
30,608,426 |
| Total Buy Value |
$7,167,688 |
$7,167,688 |
$7,174,135 |
$15,854,134 |
| Total People Bought |
3 |
3 |
4 |
10 |
| Total Buy Transactions |
4 |
4 |
5 |
20 |
| Total Shares Sold |
0 |
0 |
0 |
107,514 |
| Total Sell Value |
$0 |
$0 |
$0 |
$111,901 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hesterberg Lyndal K. |
Sr VP, Research & Development |
• – – |
2018-07-26 |
4 |
B |
$0.00 |
$0 |
D/D |
874 |
874 |
2.66 |
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2018-03-28 |
4 |
B |
$1.26 |
$0 |
I/I |
0 |
7,564,934 |
1.42 |
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2018-03-28 |
4 |
B |
$1.26 |
$5,000,000 |
D/D |
3,968,254 |
7,564,934 |
2.45 |
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2017-07-21 |
4 |
OE |
$3.25 |
$0 |
I/I |
0 |
3,596,680 |
|
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2017-07-21 |
4 |
OE |
$3.25 |
$1,755,000 |
D/D |
540,000 |
3,596,680 |
|
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2017-02-17 |
4 |
OE |
$3.25 |
$0 |
I/I |
0 |
3,056,680 |
|
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2017-02-17 |
4 |
OE |
$3.25 |
$1,381,250 |
D/D |
425,000 |
3,056,680 |
|
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2016-08-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,631,681 |
|
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2016-08-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,631,681 |
|
- |
|
| Bailey Don M |
Director |
– • – |
2016-08-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
247,001 |
|
- |
|
| Chapman Karen B. |
Vice President of ResearchOffi |
• – – |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
43,799 |
|
- |
|
| West Michael D |
Director |
– • – |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
43,799 |
|
- |
|
| Segall Judith |
Corporate SecretaryOfficer |
• – – |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,657 |
|
- |
|
| Biotime Inc |
10% Owner |
– – • |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,674,244 |
|
- |
|
| Kingsley Alfred D |
Director |
– • – |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
94,112 |
|
- |
|
| Kingsley Alfred D |
Director |
– • – |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
296,902 |
|
- |
|
| Karfunkel George |
10% Owner |
– – • |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,659,860 |
|
- |
|
142 Records found
|
|
Page 6 of 6 |
|
|
